Drugs Controller General of India (DCGI) Rajeev Singh Raghuvanshi has called for bridging the “huge gap” between biology and technology interface for an out-of-the-box research, so that the country can come out of its ‘generic’ mindset.
The quality of pharma exports from the country have to be impeccably established to sustain the export market and negate any probable trust issues, being the ‘pharmacy of the world’, he reiterated during a talk delivered at the CSIR-Indian Institute of Chemical Technology (IICT) on National Technology Day on Thursday.
Mr. Raghuvanshi said efforts were on to make the drug regulatory intervention more simpler and hassle-free for firms and sought the help of IICT to help the regulatory authority in bringing in fresh specialists to take part in subject experts committees to make the process more research-centric.
